Nephrology
2 drugs are in development for Congenital Adrenal Hyperplasia.
- Companies
- 2
- Clinical trials
- 14
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Congenital Adrenal Hyperplasia pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
| Drug | Company |
|---|---|
| tildacerfont | SPRUCE BIOSCIENCES, INC. (SPRB) |
About this indication
Congenital Adrenal Hyperplasia context
Nephrology·MeSH: Adrenal Hyperplasia, Congenital (D000312)
Also known as: Adrenal Hyperplasias, Congenital
Compare drugs
Frequently asked questions
How many drugs are in development for Congenital Adrenal Hyperplasia?
BioSniper tracks 2 drugs in development for Congenital Adrenal Hyperplasia across 2 companies.
How many clinical trials target Congenital Adrenal Hyperplasia?
There are 14 clinical trials targeting Congenital Adrenal Hyperplasia tracked by BioSniper.